Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
H Tree Capital is a London-based venture capital firm founded in 2023. The firm focuses on supporting seed-stage founders who are innovating at the intersection of computation and biology. H Tree Capital aims to transform how people live, age, and protect the planet by investing in advanced technologies that address complex biological challenges. The firm is named after the mathematical concept of fractal geometry, specifically H-trees, which reflects its commitment to deep scientific inquiry.
Currently, H Tree Capital operates with a global investment strategy, primarily targeting seed-stage companies. The firm is structured to act as a lead or co-lead investor, often committing to follow-on investments in its portfolio companies. Although the fund size has not been publicly confirmed, the firm is actively building its presence in the venture capital landscape, focusing on healthcare, biotech, and climate sectors.
H Tree Capital's founding team includes notable figures such as Rob Kniaz, a co-founder with a background in venture capital through Hoxton Ventures, and Vanela Bushi, an expert in healthcare. The firm is positioned to leverage their expertise to navigate the complexities of innovation in these critical sectors.
H Tree Capital primarily invests in seed-stage companies across the globe, with a strong emphasis on healthcare, biotech, and climate sectors. The firm typically commits between €2 million and €3 million per investment, aiming for an ownership stake of 10% to 20% in its portfolio companies. This investment strategy allows H Tree Capital to act as a lead or co-lead investor, providing substantial capital to support early-stage innovations.
The firm’s investment thesis centers on the intersection of computation and biology, particularly focusing on how AI and machine learning can enhance human and planetary health. H Tree Capital seeks to back companies that are pioneering advancements in areas such as AI-driven drug discovery, enzyme-based carbon capture, and protein folding. Their approach includes a dual strategy of supporting high-risk innovations at the seed stage while also committing to follow-on investments for companies that demonstrate significant potential.
Rob Kniaz - Co-founder. Rob has a background in venture capital as a co-founder of Hoxton Ventures, where he gained experience in supporting early-stage technology companies. He is recognized for his expertise in identifying high-potential startups and has been involved in notable deals in the London venture capital scene.
Vanela Bushi - Co-founder. Vanela is a healthcare expert with a strong focus on innovations that improve health outcomes. Her background includes extensive experience in the healthcare sector, where she has worked on various initiatives aimed at enhancing patient care and advancing medical technologies.
To pitch H Tree Capital, founders should use the contact form available on their website at htree.capital. It is recommended to include a detailed pitch deck that outlines the business model, market opportunity, and technological innovations. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
In April 2023, H Tree Capital launched its operations, focusing on seed-stage investments in healthcare, biotech, and climate sectors. The firm has been featured in various publications, including a profile in Tech.eu that highlighted its unique investment thesis at the intersection of computation and biology.
As of 2026, H Tree Capital continues to build its presence in the venture capital landscape, actively seeking innovative startups that align with its mission to enhance human and planetary health through advanced technologies.
What are H Tree Capital's investment criteria?
H Tree Capital focuses on seed-stage investments in healthcare, biotech, and climate sectors. The firm looks for startups that leverage computation and biology to address complex challenges, particularly those utilizing AI and machine learning.
How can founders pitch to H Tree Capital?
Founders can pitch to H Tree Capital through their website at htree.capital. It is advisable to include a clear outline of the business model, market opportunity, and how the technology addresses specific biological challenges.
What makes H Tree Capital different from other venture firms?
H Tree Capital differentiates itself by focusing on the intersection of computation and biology, specifically targeting innovations that enhance human and planetary health. Their expertise in these fields allows them to provide strategic support to portfolio companies.
What is the geographic scope of H Tree Capital's investments?
The firm invests globally, with a particular focus on seed-stage companies that are innovating in healthcare, biotech, and climate sectors.
What is the typical check size for investments?
H Tree Capital typically invests between €2 million and €3 million in seed-stage companies, aiming for a 10% to 20% ownership stake.
What kind of post-investment support does H Tree Capital provide?
H Tree Capital offers strategic support to its portfolio companies, leveraging its expertise in computation and biology to help founders navigate the complexities of innovation in healthcare and sustainability.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.